X-18642032-A-G
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PS4_ModeratePM2_SupportingPP4PP3_Strong
This summary comes from the ClinGen Evidence Repository: The NM_000330.4(RS1):c.647T>C variant is a missense variant encoding the substitution of Leucine with Proline at amino acid 216. This variant is absent from hemizygous individuals in gnomAD v4.1.0 (PM2_Supporting). The computational predictor REVEL gives a score of 0.969, which is above the ClinGen X-linked IRD VCEP threshold of >0.932 and predicts a damaging effect on RS1 function (PP3_strong). The computational splicing predictor SpliceAI gives a delta score of 0.00 for all predictive splice changes, which is below the ClinGen X-linked IRD VCEP threshold of >0.2 and does not predict that the variant disrupts RS1 splicing. At least one proband harboring this variant exhibits a phenotype including appearance of schisis and reduced visual acuity before age 13 years, which together are specific for X-linked retinoschisis (PMID:33460243, PP4). This variant has been reported in at least 3 apparently unrelated probands meeting the PS4 requirements of a male diagnosed with X-linked retinoschisis (PMIDs: 19324861, 19390641, 34822951, PS4_Moderate). In summary, this variant is classified as likely pathogenic for X-linked retinoschisis based on the ClinGen X-linked Inherited Retinal Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RS1 Version 1.0.0: PM2_supporting, PP3_strong, PP4, and PS4_moderate (date of approval 01/24/2025). LINK:https://erepo.genome.network/evrepo/ui/classification/CA226839/MONDO:0010725/126
Frequency
Consequence
NM_000330.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RS1 | NM_000330.4 | c.647T>C | p.Leu216Pro | missense_variant | Exon 6 of 6 | ENST00000379984.4 | NP_000321.1 | |
RS1 | XM_047442337.1 | c.551T>C | p.Leu184Pro | missense_variant | Exon 4 of 4 | XP_047298293.1 | ||
CDKL5 | NM_001037343.2 | c.2714-3975A>G | intron_variant | Intron 19 of 21 | NP_001032420.1 | |||
CDKL5 | NM_003159.3 | c.2714-3975A>G | intron_variant | Intron 18 of 20 | NP_003150.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RS1 | ENST00000379984.4 | c.647T>C | p.Leu216Pro | missense_variant | Exon 6 of 6 | 1 | NM_000330.4 | ENSP00000369320.3 | ||
CDKL5 | ENST00000379989.6 | c.2714-3975A>G | intron_variant | Intron 19 of 21 | 1 | ENSP00000369325.3 | ||||
CDKL5 | ENST00000379996.7 | c.2714-3975A>G | intron_variant | Intron 18 of 20 | 1 | ENSP00000369332.3 | ||||
RS1 | ENST00000476595.1 | n.1138T>C | non_coding_transcript_exon_variant | Exon 5 of 5 | 1 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
not provided Pathogenic:1Other:1
This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 216 of the RS1 protein (p.Leu216Pro). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with retinoschisis (PMID: 9618178, 19324861, 19390641, 33460243, 34822951). ClinVar contains an entry for this variant (Variation ID: 99014). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RS1 protein function. For these reasons, this variant has been classified as Pathogenic. -
- -
Juvenile retinoschisis Pathogenic:1
The NM_000330.4(RS1):c.647T>C variant is a missense variant encoding the substitution of Leucine with Proline at amino acid 216. This variant is absent from hemizygous individuals in gnomAD v4.1.0 (PM2_Supporting). The computational predictor REVEL gives a score of 0.969, which is above the ClinGen X-linked IRD VCEP threshold of >0.932 and predicts a damaging effect on RS1 function (PP3_strong). The computational splicing predictor SpliceAI gives a delta score of 0.00 for all predictive splice changes, which is below the ClinGen X-linked IRD VCEP threshold of >0.2 and does not predict that the variant disrupts RS1 splicing. At least one proband harboring this variant exhibits a phenotype including appearance of schisis and reduced visual acuity before age 13 years, which together are specific for X-linked retinoschisis (PMID: 33460243, PP4). This variant has been reported in at least 3 apparently unrelated probands meeting the PS4 requirements of a male diagnosed with X-linked retinoschisis (PMIDs: 19324861, 19390641, 34822951, PS4_Moderate). In summary, this variant is classified as likely pathogenic for X-linked retinoschisis based on the ClinGen X-linked Inherited Retinal Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RS1 Version 1.0.0: PM2_supporting, PP3_strong, PP4, and PS4_moderate (date of approval 01/24/2025). -
Retinal dystrophy Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at